INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | - | ₹403 Cr | ₹394 Cr | ₹18 Cr | ₹25 Cr |
What is the latest Total Debt ratio of INDEGENE ?
| Year | Total Debt |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹403 Cr |
| Mar2023 | ₹394 Cr |
| Mar2022 | ₹18 Cr |
| Mar2021 | ₹25 Cr |
How is Total Debt of INDEGENE Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹403 Cr | 2.23 | |
| Mar2023 | ₹394 Cr | 2,061.97 | |
| Mar2022 | ₹18 Cr | -26.35 | |
| Mar2021 | ₹25 Cr | - | |
Compare Total Debt of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,119.5 Cr | -7.5% | -7.5% | -6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -7.5% |
-7.5% |
-6.2% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses